drugset / Trial / NCT02722161
Olmutinib (BI 1482694) ADME Study
NaSingle-groupOpen-labelTreatment
Summary
To investigate the basic pharmacokinetics of BI 1482694, its metabolites M1 and M2, and \[14C\]-radioactivity, including mass balance, excretion pathways and metabolism following a single oral dose of \[14C\]BI 1482694 given to healthy male volunteers
Timeline
- Start
- 2016-04
- Primary completion
- 2016-06
- Completion
- 2016-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Olmutinib | Small molecule | — | Oral |
Indications
No indication recorded.